Impaired tyrosine phosphorylation of membrane type 1-matrix metalloproteinase reduces tumor cell proliferation in three-dimensional matrices and abrogates tumor growth in mice

Carcinogenesis

Volumn 29, Issue 8, 2008, Pages 1655-1664

  Nyalendo, Carine ^a,b   Beaulieu, Edith ^a   Sartelet, Hervé ^a   Michaud, Marisol ^a,b   Fontaine, Nicolas ^a   Gingras, Denis ^a   Béliveau, Richard ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; COLLAGEN TYPE 1; MATRIX METALLOPROTEINASE 14; MUTANT PROTEIN; TYROSINE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; EMBEDDING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; FIBROSARCOMA; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN TARGETING; SARCOMA CELL; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION;

ANEUPLOIDY; ANIMALS; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; FIBROSARCOMA; HUMANS; MATRIX METALLOPROTEINASE 1; MICE; NEOPLASM INVASIVENESS; PHOSPHORYLATION; PHOSPHOTYROSINE; RATS; TYROSINE;

EID: 49649112970     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn159     Document Type: Article

References (37)

1. Egeblad,M. et al. (2002) New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer, 2 161-174.
2. Edwards,D.R. et al. (1998) Cancer. Proteases - invasion and more. Nature, 394, 527-528.
3. Folgueras,A.R. et al. (2004) Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int. J. Dev. Biol., 48, 411-424.
4. van Hinsbergh,V.W. et al. (2006) Pericellular proteases in angiogenesis and vasculogenesis. Arterioscler. Thromb. Vasc. Biol. 26, 716-728.
5. Pei,D. et al. (1996) Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J. Biol. Chem., 271, 9135-9140.
6. d'Ortho,M.P. et al. (1997) Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur. J. Biochem., 250, 751-757.
7. Hiraoka,N. et al. (1998) Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell, 95, 365-377.
8. Kajita,M. et al. (2001) Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J. Cell Biol., 153 893-904.
9. Belkin,A.M. et al. (2001) Matrix-dependent proteolysis of surface trans-glutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. J. Biol. Chem., 276, 18415-18422.
10. Nakada,M. et al. (1999) Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors. Am. J. Pathol., 154, 417-428.
11. Zhai,Y. et al. (2005) Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion. Cancer Res., 65, 6543-6550.
12. Sabeh,F. et al. (2004) Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J. Cell Biol., 167, 769-781.
13. Hotary,K.B. et al. (2003) Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell, 114, 33-45.
14. Lehti,K. et al. (2000) Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain. J. Biol. Chem. 275, 15006-15013.
15. Uekita,T. et al. (2001) Cytoplasmic tail-dependent internalization of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity. J. Cell Biol., 155, 1345-1356.
16. Langlois,S. et al. (2004) Membrane type 1-matrix metalloproteinase (MT1-MMP) cooperates with sphingosine 1-phosphate to induce endothelial cell migration and morphogenic differentiation. Blood, 103, 3020-3028.
17. Gingras,D. et al. (2001) Activation of the extracellular signal-regulated protein kinase (ERK) cascade by membrane-type-1 matrix metalloproteinase (MT1-MMP). FEBS Lett., 507, 231-236.
18. Labrecque,L. et al. (2004) Src-mediated tyrosine phosphorylation of caveolin-1 induces its association with membrane type 1 matrix metalloproteinase. J. Biol. Chem., 279, 52132-52140.
19. D'Alessio,S. et al. (2008) Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism. J. Biol. Chem., 283, 87-99.
20. Nyalendo,C. et al. (2007) Src-dependent phosphorylation of membrane type I matrix metalloproteinase on cytoplasmic tyrosine 573: role in endothelial and tumor cell migration. J. Biol. Chem., 282, 15690-15699.
21. Gingras,D. et al. (2008) Sphingosine-1-phosphate induces the association of membrane-type 1 matrix metalloproteinase with p130Cas in endothelial cells. FEBS Lett., 582, 399-404.
22. Creemers,L.B. et al. (1997) Microassay for the assessment of low levels of hydroxyproline. Biotechniques, 22, 656-658.
23. Lehti,K. et al. (2002) Oligomerization through hemopexin and cytoplasmic domains regulates the activity and turnover of membrane-type 1 matrix metalloproteinase. J. Biol. Chem., 277, 8440-8448.
24. Lehti,K. et al. (1998) Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface. Biochem. J., 334 (Pt 2), 345-353.
25. Golubkov,V.S. et al. (2006) Membrane type-1 matrix metalloproteinase confers aneuploidy and tumorigenicity on mammary epithelial cells. Cancer Res., 66, 10460-10465.
26. Li,Y. et al. (2004) Cleavage of lumican by membrane-type matrix metalloproteinase-1 abrogates this proteoglycan-mediated suppression of tumor cell colony formation in soft agar. Cancer Res., 64, 7058-7064.
27. Hotary,K. et al. (2000) Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J. Cell Biol. 149, 1309-1323.
28. Itoh,Y. et al. (2006) MT1-MMP: A potent modifier of pericellular micro-environment. J. Cell. Physiol., 206, 1-8.
29. Cabodi,S. et al. (2006) p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cancer Res., 66, 4672-4680.
30. Pawlak,G. et al. (2001) Cytoskeletal changes in cell transformation and tumorigenesis. Curr. Opin. Genet. Dev., 11 41-47.
31. Kops,G.J. et al. (2005) On the road to cancer: Aneuploidy and the mitotic checkpoint. Nat. Rev. Cancer, 5, 773-785.
32. Nonaka,T. et al. (2005) Competitive disruption of the tumor-promoting function of membrane type 1 matrix metalloproteinase/ matrix metalloproteinase-14 in vivo. Mol. Cancer Ther., 4, 1157-1166.
33. Hoogsteen,I.J. et al. (2005) Colocalization of carbonic anhydrase 9 expression and cell proliferation in human head and neck squamous cell carcinoma. Clin. Cancer Res., 11, 97-106.
34. Pavelic,Z.P. et al. (1981) The relationship of blood vessel proximity and time after radiolabeled thymidine administration to tumor cell population kinetics in a transplanted mouse mammary tumor. Am. J. Pathol., 102, 84-89.
35. Hotary,K. et al. (2006) A cancer cell metalloprotease triad regulates the basement membrane transmigration program. Genes Dev. 20, 2673-2686.
36. Even-Ram,S. et al. (2005) Cell migration in 3D matrix. Curr. Opin. Cell Biol., 17, 524-532.
37. Hanahan,D. et al. (2000) The hallmarks of cancer. Cell, 100, 57-70.